Selective D-dimer testing strategy seems safe, effective

Selective D-dimer testing strategy seems safe, effective
For patients with suspected deep venous thrombosis (DVT), selective D-dimer testing is a safe and a more efficient testing strategy than universal testing, according to a study published in the Jan. 15 issue of the Annals of Internal Medicine.

(HealthDay)—For patients with suspected deep venous thrombosis (DVT), selective D-dimer testing is a safe and a more efficient testing strategy than universal testing, according to a study published in the Jan. 15 issue of the Annals of Internal Medicine.

Lori-Ann Linkins, M.D., from McMaster University in Hamilton, Canada, and colleagues randomized consecutive symptomatic patients with a first episode of suspected DVT to receive either selective testing (860 patients) or uniform testing (863 patients). Selective testing was defined as D-dimer testing in outpatients with low or moderate clinical pretest probability (C-PTP) (DVT excluded at D-dimer levels <1.0 µg/mL [low C-PTP] or <0.5 µg/mL [moderate C-PTP]) and venous ultrasonography without D-dimer testing in inpatients and outpatients with high C-PTP, while uniform testing was defined as D-dimer testing for all participants (with DVT excluded at D-dimer levels <0.5 µg/mL).

The researchers found that in both groups the incidence of symptomatic among patients not diagnosed with DVT during initial testing was 0.5 percent at three months. There was a 21.8 percent reduction in the proportion of patients who required D-dimer testing with the use of selective testing. With use of selective testing, the proportion of patients who required ultrasonography was reduced by 7.6 percent overall and by 21.0 percent for outpatients with low C-PTP.

"A selective D-dimer testing strategy seems as safe as and more efficient than having everyone undergo D-dimer testing when diagnosing a first episode of suspected DVT," the authors write.

Several authors disclosed to the pharmaceutical industry.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Aspirin may prevent DVT and PE in joint replacement patients

Feb 07, 2012

Following a total joint replacement, anticoagulation (blood thinning) drugs can prevent Deep Vein Thrombosis (DVT), a blood clot deep within the extremities, or a pulmonary embolism (PE), a complication that causes a blood ...

Recommended for you

Restrictions lifted at British bird flu farm

16 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

Recorded Ebola deaths top 7,000

Dec 20, 2014

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.